We are live on
!
Find out more
Cardiff Oncology
CRDF
CRDF
116 hedge funds and large institutions have $39.7M invested in Cardiff Oncology in 2026 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 30 increasing their positions, 37 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
908% more call options, than puts
Call options by funds: $1.19M | Put options by funds: $118K
69% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 13
5% more funds holding
Funds holding: 110 → 116 (+6)
4.49% less ownership
Funds ownership: 40.45% → 35.96% (-4.5%)
19% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 37
48% less capital invested
Capital invested by funds: $76.6M → $39.7M (-$36.8M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
116
Holders Change
+6
Holders Change %
+5.45%
% of All Funds
1.43%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
22
Increased
30
Reduced
37
Closed
13
Calls
$1.19M
Puts
$118K
Net Calls
+$1.07M
Net Calls Change
-$724K
Top Buyers
Top Sellers
| 1 |
William Blair & Company
Chicago,
Illinois
|
-$2.11M |
| 2 |
Two Sigma Investments
New York
|
-$1.06M |
| 3 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$968K |
| 4 |
Goldman Sachs
New York
|
-$512K |
| 5 |
ACA
Acorn Capital Advisors
New York
|
-$411K |
